The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMDMG.L Regulatory News (MDMG)

  • There is currently no data for MDMG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisiton of Leading Healthcare Network

29 Apr 2013 07:10

RNS Number : 4331D
MD Medical Group Investments PLC
29 April 2013
 



 

MD Medical Group Completes Acquisitionof Leading Healthcare Network in the Samara Region

29 April 2013- MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), Russia's leading provider of private women's and children's healthcare, is pleased to announce that it has completed the acquisition of the IDK Medical Company, a network of women's and children's health clinics located in the Russian region of Samara ("IDK").

The acquisition of 100% of the outstanding share capital of Vitanostra Ltd, operator of IDK, was for USD 16.1 million in cash. IDK will now be integrated into the Company, adopting the Mother & Child brand to form Mother & Child IDK Samara.

Prior to the deal completion, MD Medical received all required approvals, including approval from the Russian Federal Antimonopoly Service.

Commenting on the acquisition, Chairman of MD Medical Group, Dr Mark Kurtser said:

"We are pleased to be able to complete this acquisition, which we view as an important strategic step for the business. With IDK's business model similar to our own, we anticipate a smooth and swift integration process. Going forward, we will continue to seek opportunities to roll out our established business model in attractive and high-growth regions throughout Russia."

- Ends -

For more information, contact:

InvestorsMaxim Novikov, Head of Investor Relations

Tel: +7 495 331 16 50ir@mospmc.ru

Media

M:Communications

Tom Blackwell / Anna Yarmarkova - Moscow

Tel: +7 495 363 2846

Sarah Macleod / Hollie Vile - London

Tel: +44 20 7920 2300

mdmg@mcomgroup.com  

For further details on the transaction please refer to the management presentation on the Company's web site at www.mcclinics.com/investors/presentations/

 

 

About MD Medical Group

MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages ten modern healthcare facilities, including two hospitals and eight outpatient clinics in Moscow, St. Petersburg, Ufa and Perm. In addition, two franchised outpatient clinics operate in Kyiv and one franchised outpatient clinic in Irkutsk. In 2013, the Company expects to begin construction of its third hospital in Ufa.

The Company's largest medical facilities are the Perinatal Medical Centre (PMC), a 250-bed medical centre, which opened its doors in 2006, and Lapino Medical Hospital, a 182-bed medical centre, which opened at the end of 2012. In March 2013, the Company began construction of its third hospital in Ufa. In 2012 there were 3,253 deliveries at PMC and Lapino. Outpatient treatments at PMC and the Company's outpatient clinics totalled 446,407.

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.

About IDK

Established in 1992 and recognised as the largest independent healthcare provider in the Samara region, IDK specialises in obstetrics (maternity), gynaecology, fertility treatment, paediatrics and clinical diagnostics.

IDK's network includes two medical centres, a children's polyclinic, a clinical diagnostics centre, two outpatient clinics in Tolyatti (Samara region's second largest city) and Novokuybyshevsk and two pharmacies, giving the group one of the strongest franchises in the region. In 2012, IDK handled around 150,000 outpatient treatments and 953 IVF cycles. IDK's total revenue, as calculated in accordance with unaudited management accounts for 2012, was RUB 513 million.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQGLGDSIGDBGXC
Date   Source Headline
4th Oct 20218:00 amRNSMDMG OPENS A NEW ONCOLOGICAL CARE CENTRE
24th Sep 20214:41 pmRNSSecond Price Monitoring Extn
24th Sep 20214:35 pmRNSPrice Monitoring Extension
19th Aug 20214:40 pmRNSSecond Price Monitoring Extn
19th Aug 20214:35 pmRNSPrice Monitoring Extension
17th Aug 20219:00 amRNSEndovascular heart surgery on a newborn at MDMG
30th Jul 20214:36 pmRNSPrice Monitoring Extension
29th Jul 20218:00 amRNSMDMG REPORTS 51% GROWTH IN REVENUE IN H1 2021
1st Jul 20214:41 pmRNSSecond Price Monitoring Extn
1st Jul 20214:35 pmRNSPrice Monitoring Extension
28th Jun 20218:00 amRNSFIRST OPEN-HEART SURGERY IN MDMG LAPINO HOSPITAL
29th Apr 20218:00 amRNSMDMG POSTS 40% REVENUE GROWTH IN Q1 2021
23rd Apr 20218:00 amRNSRESULTS OF THE AGM OF SHAREHOLDERS
6th Apr 20214:41 pmRNSSecond Price Monitoring Extn
6th Apr 20214:36 pmRNSPrice Monitoring Extension
22nd Mar 20213:15 pmRNSPUBLICATION OF 2020 ANNUAL REPORT
22nd Mar 20217:30 amRNSMDMG ANNOUNCEMENT OF THE ANNUAL GENERAL MEETING
22nd Mar 20217:00 amRNSMDMG POSTS 30% EBITDA AND 56% NET PROFIT GROWTH
16th Mar 20217:00 amRNSMDMG TO ANNOUNCE FY 2020 IFRS FINANCIAL RESULTS
8th Feb 20217:00 amRNSMDMG POSTS 18% REVENUE GROWTH IN FY 2020
1st Feb 20217:00 amRNSMD MEDICAL GROUP ANNOUNCES THE LAUNCH OF LAPINO-4
29th Dec 20208:00 amRNSMDMG ANNOUNCES START OF CONSTRUCTION OF LAPINO-4
30th Nov 20204:41 pmRNSSecond Price Monitoring Extn
30th Nov 20204:36 pmRNSPrice Monitoring Extension
10th Nov 20205:15 pmRNSCORRECTION TO MDMG ANNOUNCEMENT
10th Nov 20201:00 pmRNSMD MEDICAL GROUP ANNOUNCEMENT
9th Nov 20208:00 amRNSMDMG ANNOUNCES START OF TRADING ON MOEX
9th Nov 20207:00 amRNSMDMG POSTS SUSTAINABLE RESULTS AND REVENUE GROWTH
5th Nov 20205:45 pmRNSMDMG ANNOUNCES LISTING ON THE MOSCOW EXCHANGE
2nd Nov 20207:10 amRNSMDMG SUBMITS APPLICATION TO MOSCOW EXCHANGE
17th Sep 202012:30 pmRNSMD MEDICAL GROUP OPENS NEW SURGERY CENTRE LAPINO-2
9th Sep 202010:00 amRNSINFORMATION ON DIVIDEND PAYMENT FOR H1 2020
7th Sep 20208:00 amRNSMDMG POSTS 2% REVENUE GROWTH, 6% EBITDA GROWTH
7th Sep 20207:30 amRNSMDMG TO ANNOUNCE H1 2020 IFRS RESULTS (CORRECTION)
4th Sep 20209:42 amRNSRESULTS OF THE EXTRAORDINARY GENERAL MEETING
1st Sep 202010:00 amRNSMDMG TO ANNOUNCE H1 2020 IFRS FINANCIAL RESULTS
12th Aug 20208:00 amRNSMDMG Announcement of Extraordinary General Meeting
31st Jul 20208:00 amRNSMDMG reports H1 2020 operational results
28th Jul 20204:41 pmRNSSecond Price Monitoring Extn
28th Jul 20204:35 pmRNSPrice Monitoring Extension
30th Apr 202012:07 pmRNSSecond Price Monitoring Extn
30th Apr 202012:02 pmRNSPrice Monitoring Extension
30th Apr 20208:00 amRNSMD Medical Group Increases Revenue by 7% in Q12020
24th Apr 20208:00 amRNSResults of the AGM of shareholders
14th Apr 20208:00 amRNSANNOUNCEMENT TO SHAREHOLDERS
26th Mar 20207:00 amRNSLAPINO STARTS TREATMENT OF PATIENTS WITH PNEUMONIA
23rd Mar 202010:10 amRNSPUBLICATION OF 2019 ANNUAL REPORT
23rd Mar 20207:15 amRNSMDMG ANNOUNCEMENT OF THE ANNUAL GENERAL MEETING
23rd Mar 20207:00 amRNSMDMG POSTS 10% EBITDA GROWTH IN FY 2019
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.